Skip to content

Heparin ACA Analytical Test Pack

by E.I. Dupont DE Nemours & Co., Inc.

510(k) K843201

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK843201 Date30 Nov 1984ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KFF
Device Class
Class II
Regulation
21 CFR Part 864.7525
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Heparin ACA Analytical Test Pack is a diagnostic assay device classified under the nomenclature ‘Assay, Heparin.’ It is designed for the quantitative measurement of heparin in biological samples, supporting clinical monitoring and management in hematology. This test pack facilitates accurate detection of heparin levels, aiding in the assessment of anticoagulant therapy.

This device is supplied as a single-use analytical test pack and is intended for use in clinical laboratory settings. It is regulated under FDA 510(k) clearance (K843201) and falls under product code KFF, classified as a Class II device under regulation 864.7525. The test pack requires proper storage and handling as specified in the accompanying instructions to ensure reliable performance.

Other devices from E.I. Dupont DE Nemours & Co., Inc.

See all devices from E.I. Dupont DE Nemours & Co., Inc. →

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical setting is the Heparin ACA Analytical Test Pack intended for use in, and why is this important?

    The Heparin ACA Analytical Test Pack is designed exclusively for clinical laboratory settings, where trained personnel can perform precise quantitative measurements of heparin in biological samples. This is important because accurate heparin monitoring is critical for managing anticoagulant therapy in patients, ensuring safe and effective treatment while minimizing risks like bleeding or clotting complications.

  • Is the Heparin ACA Analytical Test Pack reusable, and if not, what does this mean for cost and workflow efficiency?

    No, the Heparin ACA Analytical Test Pack is single-use only, meaning each pack is intended for one test cycle before disposal. This design ensures reliability and consistency in results, as reuse could introduce contamination or variability. While it may require more frequent restocking, it eliminates the need for cleaning or reprocessing, streamlining workflow and reducing the risk of cross-contamination in laboratory environments.

  • What storage requirements should be followed to maintain the accuracy and performance of the Heparin ACA Analytical Test Pack?

    The test pack must be stored according to the accompanying instructions to preserve its integrity and performance. While specific storage conditions (e.g., temperature, humidity) aren’t detailed here, proper handling—such as keeping it in a dry, sealed environment and away from direct light—is essential. Adhering to these guidelines ensures the assay remains effective for its intended quantitative measurement of heparin in biological samples.

  • How is the regulatory pathway for this device structured, and what does the FDA 510(k) clearance (K843201) imply about its safety and equivalence?

    The Heparin ACA Analytical Test Pack follows the FDA 510(k) clearance pathway, meaning it has been determined to be substantially equivalent to a legally marketed predicate device (as indicated by the *decision_code: SESE*). This clearance implies that the device meets FDA standards for safety and effectiveness, though it does not imply approval for specific clinical uses—only that it complies with regulatory requirements for its intended purpose as an *Assay, Heparin* in hematology.